Selected article for: "globe spread and SARS case"
Author: Oude Munnink, Bas B.; Nieuwenhuijse, David F.; Stein, Mart; O’Toole, Áine; Haverkate, Manon; Mollers, Madelief; Kamga, Sandra K.; Schapendonk, Claudia; Pronk, Mark; Lexmond, Pascal; van der Linden, Anne; Bestebroer, Theo; Chestakova, Irina; Overmars, Ronald J.; van Nieuwkoop, Stefan; Molenkamp, Richard; van der Eijk, Annemiek; GeurtsvanKessel, Corine; Vennema, Harry; Meijer, Adam; Rambaut, Andrew; van Dissel, Jaap; Sikkema, Reina S.; Timen, Aura; Koopmans, Marion
Title: Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands
  • Cord-id: 4eh1v832
  • Document date: 2020_4_25
    • ID: 4eh1v832
    Snippet: SARS-CoV-2 is a novel coronavirus that has rapidly spread across the globe. In the Netherlands, the first case of SARS-CoV-2 has been notified on the 27th of February. Here, we describe the first three weeks of the SARS-CoV-2 outbreak in the Netherlands, which started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also, outside the South of the Netherlands. The timely generation of whole genome sequences combined w
    Document: SARS-CoV-2 is a novel coronavirus that has rapidly spread across the globe. In the Netherlands, the first case of SARS-CoV-2 has been notified on the 27th of February. Here, we describe the first three weeks of the SARS-CoV-2 outbreak in the Netherlands, which started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also, outside the South of the Netherlands. The timely generation of whole genome sequences combined with epidemiological investigations facilitated early decision making in an attempt to control local transmission of SARS-CoV-2 in the Netherlands.

    Search related documents:
    Co phrase search for related documents
    • active case and acute respiratory disease: 1, 2, 3, 4, 5, 6
    • active case and additional case: 1, 2, 3, 4
    • active case and local case: 1, 2
    • active case and local cluster: 1
    • acute respiratory disease and additional case: 1, 2
    • acute respiratory disease and live animal market: 1, 2
    • acute respiratory disease and local case: 1, 2, 3, 4, 5, 6
    • acute respiratory disease and local cluster: 1
    • additional case and local case: 1, 2, 3